コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 levels are elevated in postmortem brains of schizophrenics.
2 groups; CA1 only showed changes in the SO of schizophrenics.
3 on 1 meta-analysis and 2 studies of chronic schizophrenics.
4 gh-frequency synchronization in the brain of schizophrenics.
5 iction and the high prevalence of smoking in schizophrenics.
6 eceptor subunits in the prefrontal cortex of schizophrenics.
7 echanisms producing olfactory dysfunction in schizophrenics.
8 receptor complex, may also be upregulated in schizophrenics.
9 n relation to those reported for later-onset schizophrenics.
10 Some unaffected first-degree relatives of schizophrenics also manifest cortical gray-matter defici
12 ause current therapy is ineffective for many schizophrenics and because treatment is often accompanie
13 By contrast, the cerebellar cortex of both schizophrenics and controls contained very high levels o
14 ignificantly different between first-episode schizophrenics and controls over the posterior sagittal
15 loci in a large sample of unrelated Scottish schizophrenics and controls, but failed to replicate the
17 ix pairs of individually matched brains from schizophrenics and controls, we measured the volumes and
19 mporal, and cerebellar cortex of brains from schizophrenics and from neuroleptic-treated and nonmedic
20 xamined in dorsolateral prefrontal cortex of schizophrenics and matched controls by using in situ hyb
22 caused by retinoid dysfunction are found in schizophrenics and their relatives; (ii) those loci that
23 se found in the cerebrospinal fluid (CSF) of schizophrenics, antipsychotic drugs augment NMDA activit
24 was more pronounced in frontal cortex of AT-schizophrenics, as compared to AF-schizophrenics and con
25 al deficits were present in the offspring of schizophrenics at adolescence, to examine their stabilit
26 eased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophren
27 ic mutations in mGlu1 have been described in schizophrenics creating interest in this receptor as a t
29 es were divided into 2 groups: 32 studies of schizophrenics enrolled at various illness points (25 57
33 both mRNAs were significantly reduced in the schizophrenics, having controlled for the effects of bra
34 s points (25 578 subjects) and 29 studies of schizophrenics identified at either illness onset or fir
38 sagittal thalamic area was also seen for the schizophrenics (P = .03), which was unchanged at rescan
41 ermined to have altered expression levels in schizophrenics relative to controls are involved in a nu
44 verlapped with the subregions and laminae in schizophrenics showing the most marked increases of GABA
45 re broadly consistent with the proposal that schizophrenics suffer from enhanced signaling of salienc
52 tributes to clozapine's clinical activity in schizophrenics through modulation of both muscarinic and
54 nscripts in prefrontal cortex of brains from schizophrenics were reduced by 28.0%, although this redu